Skip links

Melissa Dagless

Partner, Head of Growth and Innovation

Connect on LinkedIn
Request a call back

Melissa is a highly experienced launch marketer. In the last seven years she has launched five medicines across 150 countries. 

Melissa leads some of Uptake’s largest projects on launch and marketing capability across US, European and Asian clients and is also Head of Growth and Innovation.

Melissa started her career at GSK where she held a number of marketing and sales roles. These included Head of Marketing for Vaccines UK, Head of Strategy [including Marketing and Launch Excellence] for GSK International and Head of Haematology for GSK Oncology International.

From GSK she went to found the European Commercial business for the Japanese Pharmaceutical company, Shionogi. As VP Marketing Europe she built out the commercial teams in UK, France, Germany and Spain.

Most recently she founded and ran Accretio Limited. Accretio co-invests with Pharmaceutical companies in medicines that the Pharma company cannot focus on to ensure access to patients in the UK.  

After building a portfolio of 10+ medicines Melissa successfully exited the business in early 2018 to allow her to focus on her three passions: ensuring medicines launch successfully for patients, working with women in business, and her family.

Melissa loves to work with teams to build best-in-class launches.


Award-winning global strategic advisory for a World Health Organisation project

Using agile methodologies and an innovative approach, Melissa gained rapid alignment across the WHO, global pharmaceutical executive teams, and government departments in Ghana and Nigeria.

Read more about this important project

Identifying hidden gems of medicines to maximise impact for global pharmaceutical organisation

Melissa led a project which found commercial value locked in portfolios, developing commercial strategies which would lead to 10X revenues in five years.

Deployment of Go To Market model for a global organisation establishing in Europe

Melissa was tasked with the creation of a new European business for a pharmaceutical organisation headquartered in Japan, successfully transitioning from 2 employees to 250.

Latest thought leadership

Read the article

Contact Melissa Dagless

Book a call to discuss your next challenge

Get in touch